CRA’s Walter Colasante, Pascale Diesel, and Lev Gerlovin recently published a series of three articles in Cell & Gene on emerging gene and cell therapies and their impact on the market. Read the full series below.
How are cell and gene therapies changing drug development models?
New approaches to market access and reimbursement for gene and cell therapies
Four emerging commercialization strategies for gene and cell therapies
Part 4: Inflation Reduction Act: The indirect effects and implications of IRA price negotiations
Since passage of the Inflation Reduction Act (IRA) in August 2022, the focus of many industry analysts and pharmaceutical companies has been on two important...